Effects of Bushen Huoxue Granules on Level of Dopamine in Parkinson’s Disease Patients

YANG Minghui; LI Min; DOU Yongqi; LIU YI

doi:10.13288/j.11-2166/r.2011.04.006

您当前的位置：

首页 >

文章列表页 >

Effects of Bushen Huoxue Granules on Level of Dopamine in Parkinson’s Disease Patients

更新时间：2021-11-17

- Effects of Bushen Huoxue Granules on Level of Dopamine in Parkinson’s Disease Patients
- Journal of Traditional Chinese Medicine Vol. 52, Issue 4, Pages: 299-302(2011)
- 作者机构：
  
  中国人民解放军总医院中医研究所
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2011.04.006
  CLC： R277.7
- Published：2011
- 稿件说明：
移动端阅览
[1]杨明会,李敏,窦永起,刘毅.补肾活血颗粒对帕金森病患者脑内多巴胺水平的影响[J].中医杂志,2011,52(04):299-302.

YANG Minghui, LI Min, DOU Yongqi, et al. Effects of Bushen Huoxue Granules on Level of Dopamine in Parkinson’s Disease Patients[J]. Journal of Traditional Chinese Medicine2011, 52(4): 299-302.
[1]杨明会,李敏,窦永起,刘毅.补肾活血颗粒对帕金森病患者脑内多巴胺水平的影响[J].中医杂志,2011,52(04):299-302. DOI： 10.13288/j.11-2166/r.2011.04.006.

YANG Minghui, LI Min, DOU Yongqi, et al. Effects of Bushen Huoxue Granules on Level of Dopamine in Parkinson’s Disease Patients[J]. Journal of Traditional Chinese Medicine2011, 52(4): 299-302. DOI： 10.13288/j.11-2166/r.2011.04.006.

摘要

目的研究补肾活血颗粒对帕金森病（PD）患者脑内多巴胺（DA）水平的影响。方法采用双盲设计

将60例PD患者随机分成治疗组30例和对照组30例。两组均以西药为基础治疗

其中治疗组服用补肾活血颗粒

对照组服用安慰剂

每日2次。两组患者均以3个月为治疗观察期

疗程结束后带药随访6个月观察。采用脑电超慢涨落图（EFG）观察PD患者DA水平在入组时、3个月后、6个月后、9个月后的变化。结果对照组DA值在治疗9个月中逐渐下降

但不具有统计学意义（P>0.05）。治疗组无论在治疗观察期还是随访观察期中

DA数值都呈上升趋势

且具有统计学意义（P<0.05）。结论 PD患者脑DA水平随病情进展逐渐下降

补肾活血颗粒可以升高PD患者脑内DA水平

并且疗效稳定。

Abstract

Objective To study the effect of Bushen Huoxue Granule（Granule for reinforcing kidney and activating blood）on dopamine（DA）in Parkinson’s patients.Methods In the double-blinded clinical trial

sixty patients were randomized into two groups with 30 in each.The treatment group was treated with Bushen Huoxue Granule and the control group was with placebo

twice a day.Both groups were taking western medicine as basic treatment.The observation was carried out for 3 months.The follow-up was of 6 months after the treatment cause.Using encephalofluctuography（EFG）to measure the changes of DA in both groups at baseline time

6 and 9 months later to evaluate the effect of Bushen Huoxue Granule.Results In the control group

DA level decreased gradually after the treatment for 9 months

but there was no statistical difference（P>0.05）.In the treatment group

DA level increased in the treatment observation period and follow-up with statistical difference（P<0.05）.Conclusion The level of DA has being reduced along with the progress of PD.Bushen Huoxue Granule can increase the level of DA in the brain of PD patients with reliable effect.

关键词

Keywords

references

查看原文

Views

332

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Guiling Pa’an Pills（龟羚帕安丸） on Behavior and Levels of Serum 5-HT,DA and NE in Rats after Neural Stem Cells Transplantation with Parkinson’s Disease

The Effect of Shuji Decoction（舒肌汤） on Dopamine and Its Metabolite in Corpus Striatum of Parkinson Disease Rigidity Model Rats

Clinical Observation on Kidney-Enriching to Nourish the Liver Method for 18 Cases of Parkinson’s Disease

An Analysis of TCM Pattern and Formula for Parkinson’s Disease

An Analysis of Compatibility Proportions of Pingpa Decoction for Parkinson’s Disease with Orthogonal Test Method

Related Author

CHANG Xuehui

ZHANG Liangzhi

LI Min

LIU Jun

BAO Xiaodong

SUN Limin

WU Wei

WEI Wei

Related Institution

The Second Clinical Medical College,Henan University of Traditional Chinese Medicine

Henan University of Traditional Chinese Medicine

Traditional Chinese Medicine Hospital of Zhoukou City

Basic Medical School,Zhejiang Unieversity of Chinese Medicine

Guang’ anmen Hospital,China Academy of Chinese Medical Sciences

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰